Peter Powchik
Keine laufenden Positionen mehr
Vermögen: 161 940 $ am 31.03.2024
Profil
Peter Powchik's former jobs include being a Senior Medical Director at Sumitomo Pharma America, Inc., a Principal at Pfizer Inc., a VP-Clinical Development & Medical Affairs at Novartis Pharmaceuticals Corp., a Chief Medical Officer & Senior Vice President at Chugai Pharma USA LLC, and a Senior Vice President-Clinical Development at Regeneron Pharmaceuticals, Inc. He also served as the Global Scientific Director, Director & EVP at Vaxxinity, Inc. from 2023 to 2024.
Dr. Powchik obtained a doctorate degree from New York University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VAXXINITY INC CLASS A
0,20% | 02.10.2023 | 225 858 ( 0,20% ) | 161 940 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Peter Powchik
| Unternehmen | Position | Ende |
|---|---|---|
| VAXXINITY, INC. | Chief Tech/Sci/R&D Officer | 31.03.2024 |
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2018 |
Chugai Pharma USA LLC
 Chugai Pharma USA LLC Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma USA LLC is a private company that develops safe and effective drugs. The company is based in Bedminster, NJ. | Chief Tech/Sci/R&D Officer | 01.10.2006 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Chief Tech/Sci/R&D Officer | 01.05.2005 |
| PFIZER, INC. | Corporate Officer/Principal | 01.04.2001 |
Ausbildung von Peter Powchik
| New York University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| VAXXINITY, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Chugai Pharma USA LLC
Chugai Pharma USA LLC Medical DistributorsDistribution Services Part of Roche Holding AG, Chugai Pharma USA LLC is a private company that develops safe and effective drugs. The company is based in Bedminster, NJ. | Distribution Services |
| Chugai Pharma USA, Inc. |
